Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
暂无分享,去创建一个
J. Hogan | C. Dossier | G. Deschênes | F. Broux | G. Roussey-Kesler | V. Guigonis | V. Baudouin | C. Pietrement | V. Audard | S. Guilmin-Crépon | T. Ulinski | J. Harambat | F. Nobili | E. Plaisier | S. Tellier | D. Djeddi | D. Morin | A. Sellier-Leclerc | O. Boyer | L. Bessenay | S. Cloarec | I. Vrillon | A. Jolivot | A. Lahoche | P. Eckart | C. Faudeux | Aubriana Perez | Anne Jolivot | Vincent Audard